Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

A systematic review of patient participation during bedside handovers on wards with older patients indicates evidence is urgently needed.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Int J Older People Nurs. 2019 Feb 15:e12226. doi: 10.1111/opn.12226. [Epub ahead of print] No abstract available.

2.

Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?

Van Biesen W, Eloot S.

Clin J Am Soc Nephrol. 2019 Feb 6. pii: CJN.00500119. doi: 10.2215/CJN.00500119. [Epub ahead of print] No abstract available.

PMID:
30728168
3.

Reporting of "dialysis adequacy" as an outcome in randomised trials conducted in adults on haemodialysis.

Steyaert S, Holvoet E, Nagler E, Malfait S, Van Biesen W.

PLoS One. 2019 Feb 5;14(2):e0207045. doi: 10.1371/journal.pone.0207045. eCollection 2019.

4.

Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.

INTEGRATED group consists of (in alphabetical order), Chan C, Combes G, Davies S, Finkelstein F, Firanek C, Gomez R, Jager KJ, George VJ, Johnson DW, Lambie M, Madero M, Masakane I, McDonald S, Misra M, Mitra S, Moraes T, Nadeau-Fredette AC, Mukhopadhyay P, Perl J, Pisoni R, Robinson B, Ryu DR, Saran R, Sloand J, Sukul N, Tong A, Szeto CC, Van Biesen W.

Perit Dial Int. 2019 Jan-Feb;39(1):4-12. doi: 10.3747/pdi.2017.00242. Review.

PMID:
30692232
5.

'The effectiveness of bedside handovers: A multilevel, longitudinal study of effects on nurses and patients'.

Malfait S, Eeckloo K, Van Biesen W, Van Hecke A.

J Adv Nurs. 2019 Jan 21. doi: 10.1111/jan.13954. [Epub ahead of print]

PMID:
30666713
6.

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R.

Int Urol Nephrol. 2019 Jan 2. doi: 10.1007/s11255-018-2056-x. [Epub ahead of print]

PMID:
30604232
7.

Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group.

Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, García-García G, Gibbons E, Parra E, Hemmelder MH, Jager KJ, Ketteler M, Roberts C, Al Rohani M, Salt MJ, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Bos WJW.

Am J Kidney Dis. 2018 Dec 19. pii: S0272-6386(18)31088-6. doi: 10.1053/j.ajkd.2018.10.007. [Epub ahead of print]

8.

An International Analysis of Dialysis Services Reimbursement.

van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93. doi: 10.2215/CJN.08150718. Epub 2018 Dec 13.

PMID:
30545819
9.

Subclinical AKI: ready for primetime in clinical practice?

Vanmassenhove J, Van Biesen W, Vanholder R, Lameire N.

J Nephrol. 2019 Feb;32(1):9-16. doi: 10.1007/s40620-018-00566-y. Epub 2018 Dec 6. Review.

PMID:
30523562
10.

Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.

Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ.

PLoS One. 2018 Dec 6;13(12):e0208207. doi: 10.1371/journal.pone.0208207. eCollection 2018.

11.

Gut microbiota dynamics and uraemic toxins: one size does not fit all.

Joossens M, Faust K, Gryp T, Nguyen ATL, Wang J, Eloot S, Schepers E, Dhondt A, Pletinck A, Vieira-Silva S, Falony G, Vaneechoutte M, Vanholder R, Van Biesen W, Huys GRB, Raes J, Glorieux G.

Gut. 2018 Nov 21. pii: gutjnl-2018-317561. doi: 10.1136/gutjnl-2018-317561. [Epub ahead of print] No abstract available.

12.

Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model.

Pletinck A, Van Biesen W, Dequidt C, Eloot S.

BMC Nephrol. 2018 Oct 29;19(1):299. doi: 10.1186/s12882-018-1104-1.

13.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
14.

Treating potassium disturbances: kill the killers but avoid overkill.

Vanholder R, Van Biesen W, Nagler EV.

Acta Clin Belg. 2018 Oct 24:1-14. doi: 10.1080/17843286.2018.1531206. [Epub ahead of print]

PMID:
30353786
15.

Do Bedside Handovers Reduce Handover Duration? An Observational Study With Implications for Evidence-Based Practice.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Worldviews Evid Based Nurs. 2018 Dec;15(6):432-439. doi: 10.1111/wvn.12330. Epub 2018 Oct 15.

PMID:
30320971
16.

The effects of aerobic exercise on eGFR, blood pressure and VO2peak in patients with chronic kidney disease stages 3-4: A systematic review and meta-analysis.

Vanden Wyngaert K, Van Craenenbroeck AH, Van Biesen W, Dhondt A, Tanghe A, Van Ginckel A, Celie B, Calders P.

PLoS One. 2018 Sep 11;13(9):e0203662. doi: 10.1371/journal.pone.0203662. eCollection 2018.

17.

Is privacy a problem during bedside handovers? A practice-oriented discussion paper.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Nurs Ethics. 2018 Aug 22:969733018791348. doi: 10.1177/0969733018791348. [Epub ahead of print]

PMID:
30134750
18.

Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.

Nagler EV, Haller MC, Van Biesen W, Vanholder R, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2018 Jun 28;6:CD010965. doi: 10.1002/14651858.CD010965.pub2. Review.

PMID:
29953167
19.

Thrombomodulin and Endothelial Dysfunction: A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.

Demeulenaere M, Devreese K, Vanbelleghem H, De Zaeytijd J, Vande Walle J, Van Biesen W, Van Laecke S.

Nephron. 2018;140(1):63-73. doi: 10.1159/000490201. Epub 2018 Jun 25.

20.

Compliance with a structured bedside handover protocol: An observational, multicentred study.

Malfait S, Eeckloo K, Van Biesen W, Deryckere M, Lust E, Van Hecke A.

Int J Nurs Stud. 2018 Aug;84:12-18. doi: 10.1016/j.ijnurstu.2018.04.011. Epub 2018 Apr 24.

PMID:
29729557
21.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

22.

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.

Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.

Kidney Int. 2018 Jun;93(6):1432-1441. doi: 10.1016/j.kint.2018.01.008. Epub 2018 Apr 12.

PMID:
29656901
23.

Haste makes waste-Should current guideline recommendations for initiation of renal replacement therapy for acute kidney injury be changed?

Vanmassenhove J, Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2018 May;31(3):204-208. doi: 10.1111/sdi.12693. Epub 2018 Apr 10.

PMID:
29635792
24.

Cardiovascular disease after transplantation: an emerging role of the immune system.

Van Laecke S, Malfait T, Schepers E, Van Biesen W.

Transpl Int. 2018 Jul;31(7):689-699. doi: 10.1111/tri.13160. Epub 2018 Apr 30. Review.

PMID:
29611220
25.

Can increased vigilance for chronic kidney disease in hospitalised patients decrease late referral and improve dialysis-free survival?

De Wilde M, Speeckaert M, Van Biesen W.

BMC Nephrol. 2018 Apr 2;19(1):74. doi: 10.1186/s12882-018-0869-6.

26.

Is Kt/V useful in elderly dialysis patients? Pro and Con arguments.

Tattersall J, Farrington K, Gentile G, Kooman J, Macias Núñez JF, Nistor I, Van Biesen W, Covic A; European Renal Best Practice Guidelines Group and the European Union of Geriatric Medicine Societies (EUGMS) collaborative group for the production of guidelines on the management of older patients with CKD.

Nephrol Dial Transplant. 2018 May 1;33(5):742-750. doi: 10.1093/ndt/gfy042.

PMID:
29566211
27.

A plea for more uremic toxin research in children with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vanholder R, Vande Walle J, Eloot S.

Pediatr Nephrol. 2018 Jun;33(6):921-924. doi: 10.1007/s00467-018-3920-8. Epub 2018 Mar 2. No abstract available.

PMID:
29500629
28.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
29.

Micro-computed tomography for the quantification of blocked fibers in hemodialyzers.

Vanommeslaeghe F, Van Biesen W, Dierick M, Boone M, Dhondt A, Eloot S.

Sci Rep. 2018 Feb 8;8(1):2677. doi: 10.1038/s41598-018-20898-w.

30.

Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.

Schepers E, Glorieux G, Eloot S, Hulko M, Boschetti-de-Fierro A, Beck W, Krause B, Van Biesen W.

BMC Nephrol. 2018 Jan 5;19(1):1. doi: 10.1186/s12882-017-0808-y.

31.

Caring for Migrants and Refugees With End-Stage Kidney Disease in Europe.

Van Biesen W, Vanholder R, Ernandez T, Drewniak D, Luyckx V.

Am J Kidney Dis. 2018 May;71(5):701-709. doi: 10.1053/j.ajkd.2017.10.015. Epub 2017 Dec 21.

PMID:
29274918
32.

Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative.

Tong A, Craig JC, Nagler EV, Van Biesen W; SONG Executive Committee and the European Renal Best Practice Advisory Board; SONG Executive Committee and the European Renal Best Practice Advisory Board.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1963-1966. doi: 10.1093/ndt/gfx288. No abstract available.

PMID:
29126280
33.

Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.

Nistor I, De Sutter J, Drechsler C, Goldsmith D, Soler MJ, Tomson C, Wiecek A, Donciu MD, Bolignano D, Van Biesen W, Covic A.

Nephrol Dial Transplant. 2018 Jan 1;33(1):12-22. doi: 10.1093/ndt/gfx072. Review.

PMID:
29106631
34.

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.

Eloot S, Van Biesen W, Roels S, Delrue W, Schepers E, Dhondt A, Vanholder R, Glorieux G.

PLoS One. 2017 Oct 10;12(10):e0186010. doi: 10.1371/journal.pone.0186010. eCollection 2017.

35.

Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Van Bogaert V, Van Hoeck K, Coppens M, Roels S, Vande Walle J, Eloot S.

Nephrol Dial Transplant. 2018 Jun 1;33(6):978-986. doi: 10.1093/ndt/gfx224.

PMID:
28992139
36.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
37.

Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Holvoet E, Glorieux G, Van Hoeck K, Van Dyck M, Godefroid N, Vanholder R, Roels S, Walle JV, Eloot S.

Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.

PMID:
28939943
38.

The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.

Van Biesen W, Vanholder R, Schepers E, Glorieux G, Dhondt A, Eloot S.

Contrib Nephrol. 2017;191:168-177. doi: 10.1159/000479265. Epub 2017 Sep 14. Review.

PMID:
28910800
39.

Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial.

Van Laecke S, Caluwe R, Huybrechts I, Nagler EV, Vanholder R, Peeters P, Van Vlem B, Van Biesen W.

Ann Transplant. 2017 Aug 29;22:524-531.

40.

Diagnostic and therapeutic approach to peritonitis.

Van Biesen W, Brown EA.

Nephrol Dial Transplant. 2017 Aug 1;32(8):1283-1284. doi: 10.1093/ndt/gfx226. No abstract available.

PMID:
28810726
41.

Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation: a case report.

Steyaert S, Van Dorpe J, Hoorens A, Van Biesen W, Van Laecke S.

Acta Clin Belg. 2018 Jun;73(3):229-232. doi: 10.1080/17843286.2017.1361622. Epub 2017 Aug 14.

PMID:
28805142
42.

Mechanisms and consequences of carbamoylation.

Delanghe S, Delanghe JR, Speeckaert R, Van Biesen W, Speeckaert MM.

Nat Rev Nephrol. 2017 Sep;13(9):580-593. doi: 10.1038/nrneph.2017.103. Epub 2017 Jul 31. Review.

PMID:
28757635
43.

Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.

Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G.

Perit Dial Int. 2017 Jul-Aug;37(4):362-374. doi: 10.3747/pdi.2017.00018. Review. No abstract available.

PMID:
28676507
44.

Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.

Bonkain F, Van Hulle F, Janssens P, Catalano C, Allamani M, Stolear JC, Vandervelde D, Libertalis M, Treille S, Couttenye MM, Dhondt A, Van Biesen W, Fils JF, Tielemans C, Wissing KM.

J Vasc Access. 2017 Sep 11;18(5):436-442. doi: 10.5301/jva.5000737. Epub 2017 Jun 14.

PMID:
28623638
45.

Hyponatraemia diagnosis and treatment clinical practice guidelines.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A; Hyponatraemia Guideline Development Group.

Nefrologia. 2017 Jul - Aug;37(4):370-380. doi: 10.1016/j.nefro.2017.03.021. Epub 2017 Jun 12. English, Spanish.

46.

Correction: Iron isotopic composition of blood serum in anemia of chronic kidney disease.

Anoshkina Y, Costas-Rodríguez M, Speeckaert M, Van Biesen W, Delanghe J, Vanhaecke F.

Metallomics. 2017 Jun 21;9(6):802. doi: 10.1039/c7mt90023f.

PMID:
28573267
47.

Quantification of carbamylated albumin in serum based on capillary electrophoresis.

Delanghe S, Moerman A, Pletinck A, Schepers E, Glorieux G, Van Biesen W, Delanghe JR, Speeckaert MM.

Electrophoresis. 2017 Sep;38(17):2135-2140. doi: 10.1002/elps.201700068. Epub 2017 Jun 30.

PMID:
28556931
48.

Exploring binding characteristics and the related competition of different protein-bound uremic toxins.

Deltombe O, de Loor H, Glorieux G, Dhondt A, Van Biesen W, Meijers B, Eloot S.

Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.

PMID:
28528271
49.

Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?

Van Laecke S, Van Biesen W.

Kidney Int. 2017 Jun;91(6):1271-1274. doi: 10.1016/j.kint.2017.02.025.

PMID:
28501299
50.

Iron isotopic composition of blood serum in anemia of chronic kidney disease.

Anoshkina Y, Costas-Rodríguez M, Speeckaert M, Van Biesen W, Delanghe J, Vanhaecke F.

Metallomics. 2017 May 24;9(5):517-524. doi: 10.1039/c7mt00021a.

PMID:
28417130

Supplemental Content

Loading ...
Support Center